Shaping the Future of Sustainable Antibiotics Manufacturing through ESG Integration

Life-saving medicines, such as antibiotics, are essential — but so is the way we produce them. In a time of climate crisis, antimicrobial resistance, and global inequality, the pharmaceutical industry must take a leadership role in building a more sustainable and resilient future.

Join us for this session as we present a bold and hopeful vision for the future — one where antibiotics and other essential medicines are manufactured responsibly, equitably, and sustainably.

We will share insights from Centrient Pharmaceuticals, a global business-to-business manufacturer of foundational medicines, on how the industry can evolve through strong environmental stewardship, responsible supply chains, community engagement, and transparent governance. Discover how we are turning ambition into action by embedding ESG at the core of our business - integrating it across functions, culture and decision-making processes.

This session goes beyond discussion — it is a collective invitation to help shape a pharmaceutical ecosystem that is cleaner, fairer, and ready for the future.